This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Farazi, P. A. Articles by DePinho, R. A. Search for Related Content PubMed PubMed Citation Articles by Farazi, P. A. Articles by DePinho, R. A.

Differential Impact of Telomere Dysfunction on Initiation and Progression of Hepatocellular Carcinoma¹

Department of Medical Oncology, Dana Farber Cancer Institute [P. A. F., S. J., A. Y., K. L. R., R. A. D.]; Department of Medicine and Genetics, Harvard Medical School [P. A. F., R. A. D.]; and Department of Pathology, Brigham and Women’s Hospital [J. G.], Boston, Massachusetts 02115

Telomere maintenance and telomerase reactivation are near universal features of human hepatocellular carcinoma (HCC), yet the shorter telomeres and highly abnormal cytogenetic profiles of HCC suggest that telomere erosion and dysfunction may be operative during the formative stages of tumorigenesis. Previous studies have established that the cancer-enhancing or suppressing impact of telomere dysfunction is highly dependent on several parameters including cell type, tumor stage, and p53 status. Here, to understand better the pathogenetic role of telomere dysfunction in the initiation and progression in human HCC, we have used three mechanistically distinct liver cancer-prone model systems (urokinase plasminogen activator transgenic mice, carbon tetrachloride exposure, and diethylnistrosamine treatment) in the context of successive generations of telomerase-deficient mice null for the telomerase RNA component, mTERC. Across all of the HCC model systems, telomere dysfunction suppressed both the incidence and growth of HCC lesions, a trend that mirrored the level of intratumoral proliferative arrest and apoptosis. On the histological level, telomere dysfunction was associated with a significant increase in the number of early stage neoplastic lesions and a reciprocal decline in the occurrence of high-grade malignancies. These genetic data in the mouse indicate that telomere dysfunction exerts an opposing role in the initiation versus progression of HCC and provide a framework for understanding the intimate link among chronic liver disease, chromosomal instability, and increased HCC in humans.

This article has been cited by other articles:

				G. Aubert and P. M. Lansdorp Telomeres and Aging Physiol Rev, April 1, 2008; 88(2): 557 - 579. [Abstract] [Full Text] [PDF]

				E. Lazzerini Denchi, G. Celli, and T. de Lange Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication Genes & Dev., October 1, 2006; 20(19): 2648 - 2653. [Abstract] [Full Text] [PDF]

				N H Park, I H Song, and Y-H Chung Chronic hepatitis B in hepatocarcinogenesis. Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515. [Abstract] [Full Text] [PDF]

				P. A. Farazi, J. Glickman, J. Horner, and R. A. DePinho Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression. Cancer Res., May 1, 2006; 66(9): 4766 - 4773. [Abstract] [Full Text] [PDF]

				W. Huang, J. Zhang, M. Washington, J. Liu, J. M. Parant, G. Lozano, and D. D. Moore Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor Mol. Endocrinol., June 1, 2005; 19(6): 1646 - 1653. [Abstract] [Full Text] [PDF]

				T. DE LANGE Telomere-related Genome Instability in Cancer Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 197 - 204. [Abstract] [PDF]

				N. Erdmann, Y. Liu, and L. Harrington Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice PNAS, April 20, 2004; 101(16): 6080 - 6085. [Abstract] [Full Text] [PDF]

				T. Kondo, N. Oue, K. Yoshida, Y. Mitani, K. Naka, H. Nakayama, and W. Yasui Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma Cancer Res., January 15, 2004; 64(2): 523 - 529. [Abstract] [Full Text] [PDF]